RenovoRx, Inc. announced that it has entered into a securities purchase agreement to issue up to 6,133,414 shares at a price of $0.9964589 per share for the gross proceeds of $6,111,695 on January 26, 2024. The company raised $6,111,695? in funding pursuant to exemption provided under Regulation D. The minimum investment accepted by any outside investor is $10,000.

The transaction included participation from 92 investors. The company has paid sales commissions of $508,043 to Paulson Investment Company, LLC, Investment Banking.